• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Ranbaxy Gets USFDA Nod for Gabapentin

      Posted AtNew Kerala

      Mohali-based pharma major Ranbaxy Laboratories has recevied the final approval from US Food and Drug Administration (USFDA) for manufacturing and marketing Gabapentin capsules of 100, 300 and 400 mg.

      Ranbaxy informed BSE today "The office of generic drugs, USFDA, has determined Ranbaxy formulations to be bio-equivalent and have the same therapeutic effect as that of the reference listed drug Neurontin capsules of Pfizer."Gabapentin is prescribed for the management of postherpetic neuralgia in adults, and as adjunctive therapy in the treatment of partial Seizures with and without secondary generalisation in patients over 12 years of age with Epilepsy. It is also prescribed as adjunctive therapy in the treatment of partial seizures in pediatric patients of age 3-12 years, the company release said.

      October 10, 2005


      Share this Article!

    Back to top^